Eisai, Boston University collaborate | February 5, 2018 Issue - Vol. 96 Issue 6 | Chemical & Engineering News
Volume 96 Issue 6 | p. 15 | Concentrates
Issue Date: February 5, 2018

Eisai, Boston University collaborate

By Ryan Cross
Department: Business
Keywords: Neuroscience, Alzheimer's, microglia, Eisai, Boston University

Japanese drug company Eisai will expand its Alzheimer’s disease research through a collaboration between Boston University School of Medicine and the drug firm’s Andover innovative Medicines (AiM) Institute. The partnership is focused on the relationship between genetic variants related to Alzheimer’s and microglia, immune cells found in the brain. AiM Institute’s immuno-dementia research is part of a growing trend of searching for immune system- and inflammation-related targets to treat Alzheimer’s.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment